Tetra Bio Pharma Inc - ESG Rating & Company Profile powered by AI
The webpage contains a free Environmental, Social and Governance analysis covering Tetra Bio Pharma Inc. The report of Tetra Bio Pharma Inc employs intelligence from across the web as well as from available disclosures by Tetra Bio Pharma Inc. Browse to the end of the page for potential risks for Tetra Bio Pharma Inc based on sector, location and marketcap.
Tetra Bio Pharma Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.2; made up of an environmental score of 4.6, social score of 4.6 and governance score of 3.4.
4.2
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Novartis AG | 9.2 | High |
2 | Daiichi Sankyo Co Ltd | 8.9 | High |
1335 | PureTech Health PLC | 4.3 | High |
1335 | Youcare Pharmaceutical Group Co Ltd | 4.3 | High |
1376 | Tetra Bio Pharma Inc | 4.2 | High |
1376 | Atreca Inc | 4.2 | High |
1376 | BiondVax Pharmaceuticals Ltd | 4.2 | High |
... | ... | ... | |
2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
2749 | Zyden Gentec Ltd | 0.0 | Low |
... | ... | ... |
Frequently Asked Questions
Does Tetra Bio Pharma Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Tetra Bio Pharma Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Tetra Bio Pharma Inc report the average age of the workforce?
Sign up for free to unlockDoes Tetra Bio Pharma Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Tetra Bio Pharma Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Tetra Bio Pharma Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Tetra Bio Pharma Inc offer flexible work?
Sign up for free to unlockDoes Tetra Bio Pharma Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Tetra Bio Pharma Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Tetra Bio Pharma Inc conduct supply chain audits?
Sign up for free to unlockDoes Tetra Bio Pharma Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Tetra Bio Pharma Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Tetra Bio Pharma Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Tetra Bio Pharma Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Tetra Bio Pharma Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Tetra Bio Pharma Inc disclose water use targets?
Sign up for free to unlockDoes Tetra Bio Pharma Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Tetra Bio Pharma Inc have a product recall in the last two years?
Sign up for free to unlockDoes Tetra Bio Pharma Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Tetra Bio Pharma Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Tetra Bio Pharma Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Tetra Bio Pharma Inc disclose parental leave metrics?
Sign up for free to unlockDoes Tetra Bio Pharma Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Tetra Bio Pharma Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Tetra Bio Pharma Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Tetra Bio Pharma Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Tetra Bio Pharma Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Tetra Bio Pharma Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Tetra Bio Pharma Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Tetra Bio Pharma Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Tetra Bio Pharma Inc disclose its waste policy?
Sign up for free to unlockDoes Tetra Bio Pharma Inc report according to TCFD requirements?
Sign up for free to unlockDoes Tetra Bio Pharma Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Tetra Bio Pharma Inc disclose energy use targets?
Sign up for free to unlockDoes Tetra Bio Pharma Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Tetra Bio Pharma Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Tetra Bio Pharma Inc
These potential risks are based on the size, segment and geographies of the company.
Tetra Bio-Pharma Inc., a biopharmaceutical company, engages in the discovery and development of cannabinoid-derived drugs for inflammation, pain, ophthalmology, and oncology. The company develops PLENITUDE to treat cancer-related pain in advanced cancer patients; REBORN for the treatment of breakthrough cancer pain; Reduvo for chemotherapy-induced nausea and vomiting; ARDS-003 for the treatment of sepsis and prevention of acute respiratory distress syndrome; and SERENITY to treat cancer cachexia. It also develops PPP003 for painful dry eye and uveitis pain; and HCC011 for hepatocellular carcinoma. Tetra Bio-Pharma Inc. has an agreement with Cellvera Global Holdings LLC for the co-development of ARDS-003 as a combination product with Qifenda 400MG (Favipiravir), a commercial-stage broad-spectrum antiviral drug. The company is headquartered in Orléans, Canada.